Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... (NYSE: MRK) National Notary Association Novartis Pfizer (NYSE: PFE) Premier Inc. Roche Sanofi-Aventis (NYSE: SNY) ScheringPlough-Organon (NYSE: SGP) SNAP Diagnostics SAFE-BioPharma® is ...
2009 NOV 23 ... Atitude recently worked with the training department at Sanofi-Aventis to turn their quarterly training meeting into an all-virtual event. Directors, product ...
2009 NOV 23 ... by volume in 2010. Foreign participation in the generic sector has increased following sanofi-aventis' acquisition of Medley, recently announced in 2009. The Chamber for the ...
2009 NOV 23 ... dermal filler companies, including Suneva Medical, Allergan, Mentor, Galderma, and sanofi-aventis, to educate nurse practitioners on the newest aesthetic injectable products. The two-day ...
2009 NOV 23 ... Fovea Pharmaceuticals, which has recently entered into an agreement to be acquired by sanofi-aventis. Dyax licensed to Fovea the ocular formulation of DX-88 for the treatment of retinal ...
2009 NOV 23 ... Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Merck, Millennium, Otsuka, sanofi-aventis, and UCB. Heartbeat Digital publishes a daily blog and newsletter, The ...
2009 NOV 23 ... ImmunoGen's collaborations with Genentech (a wholly-owned member of the Roche Group), sanofi-aventis, Biogen Idec and Biotest. The most advanced compound, trastuzumab-DM1 (T-DM1), is in ...
2009 NOV 16 ... screening services. This grant was made possible through generous funding provided by Sanofi-Aventis. The Task Force continues to provide similar funding to two other ...
2009 NOV 16 ... for use, please visit www.novadel.com. Ambien is a registered trademark of sanofi-aventis. ABOUT NOVADEL PHARMA NovaDel Pharma Inc. is a specialty pharmaceutical company ...
2009 NOV 23 ... facilitate a drug's uptake and approval. Aflibercept (VEGF-Trap; Regeneron/Sanofi-Aventis) is forecast to achieve the highest level of sales among the late-phase pipeline ...
2009 NOV 16 ... announced that it has entered into agreements with Winthrop U.S., a business of sanofi-aventis U.S., to provide sales support and distribution services to Winthrop U.S. for authorized ...
2009 NOV 23 ... such as triple-negative breast cancer. "PARP inhibitors, which include Sanofi-Aventis's BSI-201 and AstraZeneca's olaparib, could dramatically improve prognoses for the ...
2009 NOV 16 ... Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), presented Safety of a Quadrivalent (A,C,Y,W-135) ...
2009 NOV 16 ... care to the benefit of the community. The report was produced with assistance from sanofi-aventis U.S. About the Dallas-Fort Worth Business Group on Health The ...
2009 NOV 16 ... 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D® 12 Hour (fexofenadine HCl 60 mg and ...
2009 NOV 16 ... poster presentations. Exelixis is co-developing XL147 and XL765 in collaboration with sanofi-aventis. Clinical data for an ongoing phase 1 trial of XL139, which is being co-developed with ...
2009 NOV 16 ... Agreement Affymetrix Signs Definitive Agreement with Panomics Sanofi-Aventis to Use Regeneron's Genetic Modification Method Monsanto to Build DEKALB ...
